ArticleScientific reports2026
Effects of stimulation frequency and pulse width in transcutaneous auricular vagus nerve stimulation on finger somatosensory function.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Transcutaneous auricular vagus nerve stimulation (taVNS) is a noninvasive electrical stimulation technique applied to the left cymba concha that may improve somatosensory impairment in stroke. Although previous studies have investigated various stimulation parameters, the optimal stimulation parameters for somatosensory impairment remain unknown. Therefore, the aim of this study was to determine the effective taVNS stimulation frequencies and pulse widths that enhance somatosensory function in the fingers. Experiments 1 and 2 each included 30 healthy, right-handed university students. In Experiment 1, the taVNS stimulation frequency was set to 30, 25, and 20 Hz, with a pulse width of 100 µs. In Experiment 2, the taVNS stimulation frequency was set to 25 Hz, with pulse widths of 300 µs and 500 µs. In Experiments 1 and 2, 2PD measurements were taken before taVNS, immediately after stimulation, and 20 min after stimulation ended. The results showed that Experiments 1, stimulation frequencies of 30 Hz, 25 Hz, and 20 Hz did not produce significant changes in 2PD thresholds. In contrast, Experiments 2, taVNS delivered at 25 Hz with pulse widths of 300 µs or 500 µs significantly reduced 2PD thresholds immediately after stimulation and again 20 min later.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.